Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2
Brendan Horton(University of Chicago), Stefani Spranger(University of Chicago), Noor Momin(Massachusetts Institute of Technology), K. Christopher García(Brigham and Women's Hospital), Maria Zagorulya(The Francis Crick Institute), Alicia D. D’Souza(Massachusetts Institute of Technology), Lora K. Picton(Stanford University), Allison Sheen(Massachusetts Institute of Technology), Chloe V. McCreery(University of Hawaiʻi at Mānoa), Yash Agarwal(Massachusetts Institute of Technology), Forest M. White(Center for Cancer Research), K. Dane Wittrup(Massachusetts Institute of Technology), Gita C. Abhiraman(Stanford University)
Cited by 25
Related Papers
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies
|Nature Protocols|2014|791
Impact of oncogenic pathways on evasion of antitumour immune responses
|Nature reviews. Cancer|2018|652